The application cases of artificial intelligence to the pharmaceutical sector are vast. Besides its accessibility and simplicity of use, artificial intelligence has significant advantages: less variability in test results, less verification activity in the case of a validated system, improved process knowledge… Chat GPT is in itself a good example of the advantages that AI may bring to the sector.
Cécile Théard-Jallu, partner, and Grégoire Froussart, associate, wrote an insight on the topic, released in the latest edition of PharmaNetwork.
To read the entire article : PHARMAnetwork magazine – last issue
